Clinical Trials Browser

Melanoma × Adjuvants, Immunologic × Clear all

NCT04594187 2026-02-17

MelPORT

Phase 2 Recruiting

Melanoma

NCT00365937 2019-03-06

Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides

Phase 1/2 Terminated

Melanoma